Anti-obesogenic properties of long-acting GLP-1 Ra could be of significant value, since obesity is associated with increased COVID-19 susceptibility and severity [45,46,52,53]. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.